Protein kinase inhibitors in the treatment of pulmonary fibrosis.
about
Update in diffuse parenchymal lung disease 2011Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response.Focal adhesion kinase protein regulates Wnt3a gene expression to control cell fate specification in the developing neural plate.IL-13 induces YY1 through the AKT pathway in lung fibroblasts.Oral submucous fibrosis: an updateInhibition of focal adhesion kinase prevents experimental lung fibrosis and myofibroblast formation.Pharmacologic therapies for idiopathic pulmonary fibrosis, past and future.Pulmonary fibrosis inducer, bleomycin, causes redox-sensitive activation of phospholipase D and cytotoxicity through formation of bioactive lipid signal mediator, phosphatidic acid, in lung microvascular endothelial cells.Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.Myofibroblast differentiation and survival in fibrotic disease.New treatment and markers of prognosis for idiopathic pulmonary fibrosis: lessons learned from translational research.Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.Myofibroblasts and their resistance to apoptosis: a possible mechanism of osteoradionecrosis.The Role of Focal Adhesion Kinase in Keratinocyte Fibrogenic Gene Expression."Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology.Fibroblasts expressing PDGF-receptor-alpha diminish during alveolar septal thinning in mice.Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis.Challenges in translating preclinical studies to effective drug therapies in idiopathic pulmonary fibrosis
P2860
Q33738931-B636CB72-EFF6-4EB9-BE74-9AB3770CACF5Q33770974-3C94BD1D-3FE5-42AD-A634-47247B75EF18Q35083482-BE21E918-CB61-4156-80C3-C54975949ECDQ35182151-774DBC4B-A401-4A9C-B4A9-3859DDF416F0Q35460437-2432D559-F796-4A13-A05E-F5E5C54F2828Q35918710-450758A3-487A-4950-81CC-3B718CDE7E72Q36264068-CCEA6DAB-6B9E-413D-AF46-0D86B2794C59Q36414620-A0ACC168-8810-4DA6-BA29-E4761D28E640Q37080510-59FDB0A3-BF73-4F03-9DE1-1A57D7E62A81Q37888661-D9A93B95-87C6-49B0-9792-8073E52BEE35Q37921386-FE45B65F-97BE-4D11-84E9-948D23C3F6A3Q38153815-1998CA95-327A-4035-B078-3A71D6532924Q39063947-B48C4B61-4535-42AF-BDCC-F7CD52A1CE71Q40649109-60054D1E-6EE0-4C8B-9DB8-D9A814275080Q41660883-8AD3BD6B-29D6-4A19-8967-A6C787E51C20Q42594342-EB618A23-D9ED-4834-A533-57E6220623C5Q48854089-AD4BA51C-E021-42DC-8DD3-56701CB8B344Q54166672-2A7B643D-3C2E-4B6B-BF48-7F4E0BC12E44Q57214985-3298B8AC-CF2B-4A3D-98AE-F1DAEFB6932A
P2860
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
@en
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
@nl
type
label
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
@en
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
@nl
prefLabel
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
@en
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
@nl
P1476
Protein kinase inhibitors in the treatment of pulmonary fibrosis.
@en
P2093
Victor J Thannickal
P304
P356
10.2174/092986708785908969
P577
2008-01-01T00:00:00Z